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Background. Patients whose symptoms are ‘unexplained by disease ’ often have a poor symptomatic outcome after
specialist consultation, but we know little about which patient factors predict this. We therefore aimed to determine
predictors of poor subjective outcome for new neurology out-patients with symptoms unexplained by disease 1 year
after the initial consultation.
Method. The Scottish Neurological Symptom Study was a 1-year prospective cohort study of patients referred to
secondary care National Health Service neurology clinics in Scotland (UK). Patients were included if the neurologist
rated their symptoms as ‘not at all ’ or only ‘ somewhat explained ’ by organic disease. Patient-rated change in health
was rated on a ﬁve-point Clinical Global Improvement (CGI) scale (‘much better ’ to ‘much worse ’) 1 year later.
Results. The 12-month outcome data were available on 716 of 1144 patients (63%). Poor outcome on the CGI
(‘unchanged’, ‘worse ’ or ‘much worse ’) was reported by 482 (67%) out of 716 patients. The only strong independent
baseline predictors were patients’ beliefs [expectation of non-recovery (odds ratio [OR] 2.04, 95% conﬁdence interval
[CI] 1.40–2.96), non-attribution of symptoms to psychological factors (OR 2.22, 95% CI 1.51–3.26)] and the receipt of
illness-related ﬁnancial beneﬁts (OR 2.30, 95% CI 1.37–3.86). Together, these factors predicted 13% of the variance in
outcome.
Conclusions. Of the patients, two-thirds had a poor outcome at 1 year. Illness beliefs and ﬁnancial beneﬁts are more
useful in predicting poor outcome than the number of symptoms, disability and distress.
Received 23 April 2009 ; Revised 8 June 2009 ; Accepted 16 June 2009 ; First published online 23 July 2009
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Introduction
Patients whose symptoms are regarded as ‘unex-
plained by disease’ are frequently encountered in all
medical settings (Gureje et al. 1997). Synonyms for such
symptoms include ‘medically unexplained’, ‘ soma-
toform’ and ‘functional ’ (Sharpe, 2002). Symptoms
that are considered by the assessing doctors to be
‘not at all ’ or only ‘somewhat ’ explained by disease
account for about a third of new out-patient visits to
secondary medical care services, such as neurology
out-patient clinics. They often do not improve after
the specialist consultation (Carson et al. 2003) and may
become associated with chronic disability (Carson
et al. 2000 ; Kroenke, 2003). However, we know rela-
tively little about which patient characteristics predict
a poor post-consultation outcome for these patients.
Our aim was therefore to determine the patient
characteristics that predicted a poor patient-reported
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1-year outcome for patients newly referred to neurol-
ogy out-patient clinics with symptoms that were rated
by the assessing neurologist as ‘not at all ’ or only
‘somewhat ’ explained by disease. Based on previous
reports of predictors of subjective outcome in other
similar symptomatic conditions, we hypothesized that
the following variables would predict poor outcome:
greater number of physical symptoms (Speckens et al.
1996b) ; poorer physical functioning (Carson et al.
2003) ; greater emotional distress (Bombardier &
Buchwald, 1995) ; general worry about health
(Kroenke & Jackson, 1998) ; the belief that they would
not recover (Mondloch et al. 2001) ; the belief that the
symptoms were not aﬀected by psychological factors
(Vercoulen et al. 1996) ; and being in receipt of illness-
related ﬁnancial beneﬁts (Atlas et al. 2006).
Method
The study was part of the Scottish Neurological
Symptom Survey, a prospective, multi-centre, Scottish
national study of a representative cohort of newly
referred neurology out-patients.
Participating clinics
Of the 38 consultant neurologists working in the four
Scottish National Health Service (NHS) neurology
centres, 36 participated. Patients were recruited from
their general neurology clinics (including their super-
vised trainee clinics) in the main Scottish neurologi-
cal centres (at Aberdeen, Dundee, Edinburgh and
Glasgow, all in the UK) and some of their associated
peripheral clinics (at Airdrie, East Kilbride, Falkirk,
Inverness, Perth, Stirling, Vale of Leven and Wishaw,
all in the UK) between December 2002 and February
2004. All the clinics sampled took mainly general prac-
tice referrals, with patients allocated by medical re-
cords staﬀ according to availability of appointment.
Specialist clinics, where patients required a suspected
speciﬁc diagnosis to attend (such as acute neurovas-
cular and multiple sclerosis clinics), were excluded as
were ‘urgent case ’ emergency clinics.
Patients
All patients newly referred to the participating neur-
ology out-patient clinics were potentially eligible for
inclusion. The exclusion criteria were : age<16 years,
cognitive impairment of a degree that precluded in-
formed consent, inability to read English, or if the
neurologist identiﬁed the patient as unsuitable for
the study (for example, too distressed or terminally
ill). New patients included patients with existing
neurological diagnoses who had been re-referred
from primary care. Patients gave informed consent to
be included in the study. We studied patients whom
the neurologist had rated as having symptoms ‘not at
all ’ or only ‘somewhat ’ explained by disease (see
below).
Procedure
Patients were sent information about the study prior
to their appointment with the neurologist. After the
consultation the patients were invited by their
neurologist to speak to a research assistant. Written
consent was obtained from those patients willing to
participate. A rating of how explained the symptoms
were by disease was obtained from the assessing
neurologist (see below). Baseline data were collected
from the patients immediately after the initial con-
sultation using a questionnaire. At 1 year after the
initial consultation, outcome data were sought from
the patients by questionnaires posted to their homes.
Patients who failed to respond were sent another copy
of the questionnaire and those who still failed to re-
spond were contacted by telephone and reminded.
Questionnaires were completed by telephone inter-
view if necessary.
Measures
Completed by neurologists
The neurologists completed a questionnaire for each
patient which asked, ‘To what extent do you think
this patient’s clinical symptoms are explained by or-
ganic disease?’ Responses were made on a four-point
Likert-type scale : ‘not at all ’, ‘ somewhat’, ‘ largely ’ or
‘completely ’ (Carson et al. 2000). Operational criteria
were provided to guide these ratings (see Appendix).
Patients whose symptoms were rated as ‘not at all ’ or
only ‘somewhat ’ explained were combined to make
a category of ‘symptoms unexplained by disease’.
Completed by patients
The measures listed below were collected from the
patient by questionnaire immediately after the initial
consultation :
(1) Demographics : age, sex and marital status.
(2) Number of physical symptoms. This was
measured using the Patient Health Questionnaire
checklist of the 15 commonest physical symptoms
presenting to primary care (excluding upper res-
piratory tract infections) and with the sexual
and menstrual items removed to leave 13 items
(Kroenke et al. 2002). In order to see if the inclusion
of neurological symptoms made a diﬀerence we
created a longer symptom score by supplementing
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these items with nine symptoms common in neur-
ology patients judged to have symptoms unex-
plained by disease (Lempert et al. 1990) to make
a 22-item scale. The total number of symptoms
endorsed on each scale was calculated for each
patient.
(3) Physical function. This was measured using the
physical function subscale of the Medical Out-
comes Study Short-Form 12-item Scale (SF12)
(Ware et al. 1996).
(4) Emotional distress. This was measured by the total
score on the Hospital Anxiety and Depression
Scale (HADS) (Zigmond & Snaith, 1983).
(5) Illness beliefs. Two categories of belief were
assessed:
(a) patients’ beliefs about outcome were measured
using an item from the Illness Perceptions
Questionnaire (IPQ; Weinman et al. 1996) : ‘My
symptoms are likely to be permanent rather
than temporary’. Responses were made on
a ﬁve-point Likert scale (‘strongly agree’,
‘agree’, ‘neither agree nor disagree ’, ‘dis-
agree’, ‘ strongly disagree ’). The responses
‘agree’ and ‘strongly agree’ were combined to
indicate an expectation of poor outcome.
(b) patients’ attribution of symptoms to psycho-
logical factors was measured using two other
items from the IPQ. These were: ‘Possible
causes of my symptoms are stress or worry’
and possible causes of my symptoms are ‘My
emotional state e.g. feeling down, lonely, an-
xious or empty’. Responses were on a similar
ﬁve-point Likert scale and those who recorded
‘agree’ and ‘strongly agree’ on either item
were coded as having made a psychological
attribution.
Patients’ worry about health was assessed using the
three items from the Whiteley Index (Speckens et al.
1996a) : ‘Do you worry a lot about your health? ’,
‘Do you often worry about the possibility you have a
serious illness? ’ and ‘If a disease is brought to your
attention (e.g. on television, radio, newspapers, or by
someone you know), do you worry about getting it
yourself? ’. Each item was scored as present or absent
and a total score (0–3) calculated with a greater score
indicating more worry.
Receipt of health-related ﬁnancial beneﬁts (inca-
pacity beneﬁt or disability living allowance) was re-
corded from patients’ self-report.
At follow-up, patients were asked to complete a
ﬁve-point self-rated scale of Clinical Global Improve-
ment (CGI) which asked the patients to compare their
current ‘general health’ with that when they ﬁrst
attended the neurology clinic on a ﬁve-point scale
(‘much worse ’ ; ‘worse ’ ; ‘not changed’ ; ‘better ’ ;
‘much better ’) (Guy, 1976). They were also asked to
make the same rating for improvement in their
presenting symptoms (IPS).
Analysis
First we computed the mean baseline symptoms
score, SF12 physical function score and total HADS
score for the full sample and compared the whole
baseline sample with those on whom we had
follow-up data using t tests and x2 tests as appropriate.
We then described outcome on the CGI and IPS scales.
The CGI health score was used to deﬁne two groups:
good outcome (CGI: ‘much better ’ or ‘somewhat
better ’) and poor outcome (CGI: ‘ just the same’,
‘ somewhat worse ’, ‘much worse ’).
We determined predictors of poor outcome using
logistic regression models to describe the relationship
between the baseline covariates and outcome. This
was done by calculating both univariate and fully
adjusted multivariate odds ratios, and the correspond-
ing 95% conﬁdence intervals. Continuous and ordinal
variables were grouped rather than making the
strong assumption of linear relationships between the
measure and the log odds of poor outcome. When
the grouped odds ratios did clearly show a linear
eﬀect, we ran sensitivity analyses taking the corre-
sponding variables as continuous. We quantiﬁed the
proportion of the variability in outcome explained
by the regression models using Nagelkerke’s R2, an
analogue for logistic regression of R2, the coeﬃcient of
determination.
Ethical approval
Ethical approval for the study was granted by a Multi-
centre Research Ethics Committee.
Results
Recruitment and follow-up
Recruitment is described in Fig. 1. A total of 3781
patients participated in the study representing 91%
(3781 out of 4161) of those attending the designated
clinics. Neurologists rated 1144 of these patients (30%
of the total) as having symptoms that were unex-
plained by disease [446 out of 3781 (12%) were ‘not at
all explained’ and 698 out of 3781 (18%) were ‘some-
what explained’ by disease].
The 12-month outcome data were available on 716
(63%) out of the 1144 of the recruited sample. This
analysed sample was similar to the initial sample on
most measured variables but had fewer males and a
lower average HADS score (see Table 1). Although
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statistically signiﬁcant, the diﬀerences on these
variables were not substantial.
Outcome
At follow-up, poor outcome (‘unchanged’, ‘worse ’ or
‘much worse ’) was reported by 482 (67%) out of
716 patients on the CGI and by 422 (59%) out of 714
patients on the IPS. All categories of outcome are
shown in Table 2 and Fig. 2.
Predictors of poor outcome
In the univariate analysis (see Table 3) poor outcome,
as measured by the CGI health score, was predicted
by older age, poorer physical functioning, greater
symptom count, greater emotional distress, an expec-
tation of non-recovery, not attributing symptoms to
psychological factors and the receipt of health-related
ﬁnancial beneﬁts measured at the initial assessment.
Sex and worry about health did not predict outcome.
(In a sensitivity analysis treating the grouped variables
as continuous the only substantive change was for
symptom count, where the p value decreased from
0.07 to 0.002.)
In the multivariate analysis (see Table 3) the only
strong independent predictors of a poor outcome were
the patients’ beliefs in expectation of non-recovery,
non-attribution of symptoms to psychological factors,
and the receipt of health-related ﬁnancial beneﬁts
at the time of the initial consultation. Each of these
three factors was associated with approximately a
doubling of the odds of a poor outcome. The HADS
emotional distress score was of only borderline stat-
istical signiﬁcance (p=0.043) and without a clear
‘dose–response ’ eﬀect. When the grouped variables
4161 Patients available for recruitment
3892 Patients gave consent 
Patients excluded, n = 138
(cognitively impaired, n = 80; language
difficulties, n = 17; considered by doctor as
unsuitable, n = 15; too physically disabled or
ill, n = 12; no reason recorded, n = 10;
behavioural problems, n = 3; too young, n =1)
Refused to participate, n = 269
Did not attend, n = 926
Clinic cancelled, n = 137
'Mis-referral', n = 4
Not a new patient, n = 3
Patient did not complete assessment, 
n = 101; neurologist ratings not
traceable, n = 10
3781 Patients in study sample
1144 Patients with symptoms 'not at all' or 
'somewhat' explained by disease
716 Patients, with symptoms 'not at all' or
'somewhat' explained by disease, followed
up at 12 months
Patients with symptoms 'completely'
(n = 1697) or 'largely' (n = 967)
explained by disease
Patients on whom outcome data could
not be collected, n = 428
5369 Patients offered neurology
new patient appointment
4299 Patients seen in clinic
Fig. 1. Study ﬂow chart.
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were included in the model as being continuous, the
p value for the HADS distress score changed to 0.14,
and the p value for age to 0.045. Substituting the
22-item symptom score (with additional neurological
symptoms) for the 13-item score made no substantial
diﬀerence to the model, indicating that adding com-
mon neurological symptoms to the score made no
diﬀerence.
Nagelkerke’s R2 was 13% for the model including
only the three strong independent predictors and was
16% for the full multivariate model including all of
the 10 variables listed in Table 3. Thus, although each
of the three highlighted variables were independently
associated with approximately a doubling of the odds
of a poor outcome, they collectively accounted for only
a small proportion of the variability in outcome. The
Table 1. Description of baseline variables of patients with symptoms unexplained by
disease, on which 12-month data were available, compared with those patients on whom
these data were missing
Baseline variable
Follow-up
data
No follow-up
data pa
Sample size, n 716 428
Mean age, years (S.D.) 46 (14) 40 (14) <0.001
Males, n (%) 226 (32) 171 (40) 0.004
Disease ‘not at all explained ’, n (%) 280 (39) 166 (39) 0.91
Mean total symptom count, 13 items (S.D.) 5.5 (3.1) 5.8 (3.2) 0.10
Mean SF12 physical function (S.D.) 63 (38) 65 (38) 0.57
Mean total HADS distress scoreb (S.D.) 13.3 (8.7) 14.8 (9.2) 0.006
Negative expectation of recoveryc, n (%) 276 (39) 158 (37) 0.65
Psychological attributiond, n (%) 353 (49) 203 (48) 0.62
Mean illness worry scoree (S.D.) 0.84 (1.01) 0.93 (0.99) 0.13
In receipt of ﬁnancial beneﬁts, n (%) 197 (28) 110 (26) 0.54
Neurological diagnosis, n (%) 0.22
Disease with unexplained symptoms 182 (25) 111 (26)
Headache diagnosis 176 (25) 116 (27)
Conversion symptomsf 124 (17) 85 (20)
Other, e.g. pain, fatigue 234 (33) 116 (27)
S.D., Standard deviation ; HADS, Hospital Anxiety and Depression Scale ; SF12,
Medical Outcomes Study Short-Form 12-item Scale.
aMeans were compared using t tests and the other variables were compared
using x2 tests.
b Total HADS is the sum of the depression and anxiety scales.
c Negative expectation of recovery was deﬁned as ‘agree ’ and ‘strongly agree ’
with the statement ‘My symptoms are likely to be permanent rather than temporary ’.
d Psychological attribution was deﬁned as ‘agree ’ and ‘ strongly agree ’ to at least
one of the following statements : ‘Possible causes of my symptoms are stress
or worry ’ or ‘My emotional state e.g. feeling down, lonely, anxious or empty ’.
e On scale of 0 to 3, with a greater score indicating more worry.
fWeakness, sensory symptoms, attacks resembling epilepsy or movement
disorders considered unexplained by disease.
Table 2. Outcome at 12 months on Clinical Global Improvement scale (n=716) and on Improvement in Presenting Symptom scale
(n=714)
Outcome variable Much worse Worse No change Better Much better
Clinical Global Improvement, n (%) 20 (3) 116 (16) 346 (48) 161 (22) 73 (10)
Improvement in Presenting Symptom scale, n (%) 20 (3) 104 (15) 288 (41) 179 (25) 113 (16)
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remaining seven variables added very little predictive
power. This also demonstrates that the lack of stat-
istical signiﬁcance of the additional variables in the
multivariate model was not due to correlated covari-
ates masking the eﬀects of each other.
Discussion
This is, to our knowledge, the ﬁrst large prospec-
tive multi-centre study of predictors of outcome for
neurology out-patients with symptoms rated as
unexplained by disease. We found that the outcome
for these patients was surprisingly poor ; only a third
rated themselves as improved in health 1 year after the
initial neurology consultation. Poor outcome was best
predicted by the patients’ own beliefs (about the likely
outcome of their symptoms, and the role of psycho-
logical factors in causing them), and by the reported
receipt of health-related ﬁnancial beneﬁts. Contrary
to our initial hypotheses, outcome was not indepen-
dently predicted by the baseline number of physical
symptoms that patients reported, the reported severity
of their disability, the degree of emotional distress
or by their reported general worry about health. Nor
was it explained by the degree to which the neurol-
ogist regarded the symptoms to be unexplained by
disease.
The main strength of this study is that it included
a large representative sample of new neurology out-
patients. All four Scottish neurology centres (serving
a population of ﬁve million people), almost every
Scottish neurologist and most (91%) of the eligible
patients participated. The initial sample can therefore
be regarded as representative of out-patient general
neurological practice, at least in the UK NHS.
The study also had limitations : First, we did not
achieve complete follow-up; despite our best eﬀorts
we were unable to obtain outcome data from 37%
of the sample. There were, however, no substantial
baseline diﬀerences between those on whom we did
have outcome data and those with missing data (not
surprisingly those with missing data included a
greater proportion of younger persons and males).
Furthermore, selection bias with respect to the covari-
ates is less of a limitation for regression modelling
than it is for estimating event rates. Second, it might
be argued that poor outcome may in some cases have
been due to the development of disease. This was not
the case, however (data reported elsewhere). Further-
more, the degree to which symptoms were explained
by disease at baseline did not predict outcome. Third,
we did not obtain a systematic description of treat-
ment given by neurologists or others in the interval
between baseline and follow-up. However, the study
represents the naturalistic outcome for such patients
in NHS practice and the evidence we do have
suggests that few speciﬁc treatments were given.
Fourth, although each of the three main variables in
our multivariate model was associated with doubling
the odds for poor outcome, together they only ac-
counted for a modest amount of variance in outcome.
This probably reﬂects the complexity of factors that
determine outcome for patients with this diagnosis.
Fifth, there are other potential predictors of outcome
that we did not measure. For example, recently pub-
lished studies of symptom outcome have included a
wider range of patient illness beliefs (Frostholm et al.
2007 ; Foster et al. 2008), whereas others have high-
lighted the role of duration of symptoms, patient per-
sonality, or changes in personal relationships, family
problems and social circumstances in predicting out-
come (Craig et al. 1994 ; Crimlisk et al. 1998; Reuber
et al. 2007b), none of which we measured. Sixth,
we measured the outcome with a global self-rated
measure of improvement. Whilst the patients’ rating
of improvement in their main symptoms was similar,
it was not identical and other more speciﬁc measures
such as that of other symptoms or disability may have
given diﬀerent results (Reuber et al. 2005). In addition,
ratings by persons other than the patient, such as the
physician or a family member, or more ‘objective ’
outcomes such as return to work may also have
produced diﬀerent results.
Other studies have reported a poor outcome for
patients who present with symptoms unexplained by
disease (Speckens et al. 1996b). This has especially
been the case for patients who have been referred to
specialist medical services (Couprie et al. 1995 ; Barsky
et al. 1996 ; Vercoulen et al. 1996 ; Crimlisk et al. 1998 ;
Carson et al. 2003). However, we know little about
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Table 3. Univariate and multivariate analysis of predictors of poor outcomea at 12 months
Variable Total n
Poor
outcome,
n (%)
Univariate analysis Multivariate analysis
OR for poor
outcome
(95% CI) p
Adjusted OR for
poor outcome
(95% CI)
Adjusted
p
Age, years 716 482 0.003 0.13
f35 173 97 (56) 1.0 1.0
36–45 197 134 (68) 1.67 (1.09–2.55) 1.51 (0.95–2.38)
46–55 170 123 (72) 2.05 (1.31–3.22) 1.67 (1.02–2.73)
o56 176 128 (73) 2.09 (1.34–3.27) 1.61 (0.98–2.65)
Sex 716 482 0.84 0.88
Male 226 150 (66) 1.0 1.0
Female 490 332 (68) 1.06 (0.76–1.49) 1.03 (0.70–1.50)
‘Organicity ’ 716 482 0.29 0.67
‘Not at all explained ’ 280 182 (65) 1.0 1.0
‘Somewhat explained ’ 436 300 (69) 1.19 (0.86–1.63) 1.08 (0.76–1.53)
Symptom count 713 480 0.07 0.62
0–2 134 79 (59) 1.0 1.0
3–5 243 162 (67) 1.39 (0.90–2.15) 1.08 (0.67–1.76)
6–8 208 145 (70) 1.60 (1.02–2.52) 1.24 (0.73–2.12)
9–13 128 94 (73) 1.92 (1.14–3.24) 0.87 (0.43–1.74)
SF12 physical function 716 482 <0.001 0.93
0 130 107 (82) 3.21 (1.94–5.33) 1.35 (0.68–2.67)
25 67 52 (78) 2.40 (1.29–4.45) 1.26 (0.61–2.60)
50 109 74 (68) 1.46 (0.92–2.32) 1.14 (0.67–1.94)
75 109 71 (65) 1.29 (0.82–2.04) 1.06 (0.64–1.76)
100 301 178 (59) 1.0 1.0
HADS distress 714 480 0.005 0.043
0–7 208 136 (65) 1.0 1.0
8–14 226 134 (59) 0.77 (0.52–1.14) 0.75 (0.48–1.16)
15–21 159 118 (74) 1.52 (0.97–2.40) 1.47 (0.84–2.56)
o22 121 92 (76) 1.68 (1.01–2.79) 1.35 (0.68–2.67)
Negative expectation
of recovery
713 479 <0.001 <0.001
No 437 261 (60) 1.0 1.0
Yes 276 218 (79) 2.53 (1.79–3.59) 2.04 (1.40–2.96)
Psychological
attribution
716 482 0.002 <0.001
No 363 265 (73) 1.69 (1.24–2.32) 2.22 (1.51–3.26)
Yes 353 217 (61) 1.0 1.0
Illness worry 712 480 0.45 0.55
0 361 235 (65) 1.0 1.0
1 169 120 (71) 1.31 (0.88–1.95) 1.24 (0.80–1.93)
2 117 78 (67) 1.07 (0.69–1.67) 1.06 (0.63–1.77)
3 65 47 (72) 1.40 (0.78–2.51) 1.54 (0.78–3.04)
Receipt of beneﬁts 713 479 <0.001 0.002
No 516 316 (61) 1.0 1.0
Yes 197 163 (83) 3.03 (2.01–4.57) 2.30 (1.37–3.86)
OR, Odds ratio ; CI, conﬁdence interval ; SF12, Medical Outcomes Study Short-Form 12-item Scale ; HADS, Hospital Anxiety
and Depression Scale.
a Global Clinical Improvement rated as ‘ just the same’, ‘ somewhat worse ’ or ‘much worse ’.
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what patient characteristics predict poor outcome.
The ﬁnding that patients’ beliefs about their symp-
toms were strong independent predictors of outcome,
whereas variables such as number of reported symp-
toms and self-rated disability was not, surprised us.
There is, however, evidence from studies of other
conditions that patients’ beliefs about their illness can
predict outcome (Petrie et al. 2007). The belief that
one will not recover has been found to predict poor
subjective outcome for patients suﬀering from pain
and patients who have had surgery, a myocardial
infarction or a major injury (Mondloch et al. 2001 ; Cole
et al. 2002 ; Holm et al. 2008). Whilst this association
might simply reﬂect patients repeating the prognosti-
cation given to them by their doctors, this seems an
unlikely explanation for symptoms unexplained by
disease. These predictions are therefore likely to be the
patients’ own. The power of the patients’ own predic-
tion might mean that they are able to predict their
outcome because of personal knowledge. It is also
possible that such a belief plays a causal role in shap-
ing outcome by acting as a self-fulﬁlling prophecy;
that is if a person starts to think and behave as if they
have a permanent illness, that is what they actually
get.
The other belief that predicted outcome in our study
was non-attribution of symptoms to psychological
causes. This has been previously reported to predict
outcome for patients with the chronic fatigue syn-
drome (Joyce et al. 1997) and also for patients with
non-epileptic attack disorder (Ettinger et al. 1999). The
failure of patients to agree with the doctor in attribu-
ting somatic symptoms to psychological causes is the
essence of the idea of somatization (Lipowski, 1987).
The concept is, however, now widely regarded as
overly simplistic, as chronic somatic symptoms,
whether associated with disease or not, are all likely
to have multiple biological, psychological and social
perpetuating factors (Sharpe et al. 2006). A tendency
not to make a link between symptoms and stress or
emotional problems could, however, contribute to
a poor outcome by leading to a failure to address
relevant psychological and social problems.
The ﬁnding that being in receipt of ﬁnancial beneﬁts
at the time of the initial consultation also predicted
poor outcome will perhaps not come as a surprise to
many clinicians. The receipt of such beneﬁts has been
reported to predict a poorer outcome in patients with
a wide range of conditions both unexplained and ex-
plained by disease. They include back pain associated
with a herniated lumbar disc (Atlas et al. 2006), closed
head injury (Binder & Rohling, 1996) and neck pain
(Landers et al. 2007). Whilst the explanation for this
association remains uncertain, a causal relationship is
supported by a study of whiplash injury which found
that absence of compensation was associated with
quicker subjective recovery (Cassidy et al. 2000), and
a pilot study of psychotherapy for neurological
symptoms unexplained by disease found that ﬁnancial
beneﬁts predicted poorer outcome from treatment
(Reuber et al. 2007a). Hence, it is possible that payment
consequent on having symptoms and disability acts
to perpetuate them.
We also found that some of our hypothesized pre-
dictors did not independently predict poor outcome.
The number of somatic symptoms that the patient
reports has been a key variable in diﬀerentiating
somatoform disorders from simple symptoms prob-
lems (Mayou et al. 2005) and has previously been
found to predict outcome in medical patients (Jackson
& Passamonti, 2005; Jackson et al. 2006). We found it to
be a predictor of outcome but only in the univariate
analysis (and if entered as a continuous variable) ;
it dropped out of the multivariate model. Similarly,
poorer physical functioning and greater emotional
distress were predictors in the univariate analysis but
did not contribute to the multivariate model (HADS
did but only in a minor and non-linear fashion).
General worry about health predicted in neither
model. Hence, speciﬁc patient-reported illness beliefs
and receipt of beneﬁts proved to be better predictors
of patients’ outcome than these more general patient
characteristics of symptoms, distress and functioning
which are more commonly recorded at assessment.
The ﬁnding of an association of poor subjective
outcome with speciﬁc beliefs and being in receipt
of health-related ﬁnancial beneﬁts in patients with
symptoms unexplained by disease has important im-
plications. First, asking about these factors may assist
the assessing clinician in predicting poor outcome
1 year later. Second, they may point the way to
a greater understanding of the psychological and
social mechanisms that determine poor outcome.
Third, they lend support to the idea that interventions
which change these variables may improve the out-
come for this patient group. As well as providing
theoretical underpinning for the application of cogni-
tive behaviour therapy (Kroenke & Swindle, 2000)
they suggest that doctors should take time to discuss
their patients’ own beliefs about their illness. Similarly
they emphasize that those policies that determine
health-related ﬁnancial beneﬁts may need to be
amended if we are to maximize the chance of recovery
(Waddell et al. 2007).
Conclusion
A large proportion of patients assessed by a neurol-
ogist as having symptoms not at all or only somewhat
explained by disease had a poor self-rated outcome a
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year after the initial specialist consultation and this
was predicted by the patients’ beliefs and receipt of
ﬁnancial beneﬁts.
Appendix
Guidance given to doctors on ‘What we mean by
organic disease ’
The following is meant as a guide for this study and
we are aware that any divisions like this are imper-
fect. Many patients have a mixture of symptoms,
syndromes or disease and the ﬁnal coding is your
decision based on these guidelines.
‘Not organic disease ’
For the purpose of this study this includes : tension
headache ; aetiologically controversial symptom ‘syn-
dromes’ (e.g. ﬁbromyalgia, irritable bowel syndrome) ;
physiologically explained processes which are thought
to be linked to emotional symptoms (e.g. hyper-
ventilation) ; emotional disorders (e.g. depression,
anxiety, panic disorder).
‘Organic disease ’
For the purpose of this study this includes : migraine ;
any neurological disorder with a known pathological
basis ; neurological disorders with deﬁned and charac-
teristic features but without a clear pathological basis
(e.g. Gilles de la Tourette syndrome, idiopathic focal
dystonia) ; physiological explained processes NOT
linked to emotional symptoms (e.g. micturition
syncope) ; psychotic disorder.
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